Editorial Policies

Focus and Scope

The Journal of Advanced Therapies and Medical Innovation Sciences (J-ATAMIS) is an international peer-reviewed journal dedicated to publishing high quality reports, studies, trials, investigations and hypotheses including all aspects of scientifc and therapeutic innovation in health and disease. It covers a broad area of interest from molecules to clinical practice, with special expertise in molecular and nanotechnology science, in biologics, advanced medical devices, novel therapeutics, innovation, biotechnology and venture capital funding of medical innovations in daignostics, monitoring, therapeutics devices and big data sciences.


Section Policies


Checked Open Submissions Checked Indexed Checked Peer Reviewed


Checked Open Submissions Checked Indexed Checked Peer Reviewed

Original Article

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Letter to the Editor

Checked Open Submissions Checked Indexed Checked Peer Reviewed


Checked Open Submissions Checked Indexed Checked Peer Reviewed

Peer Review Process

The journal depends on expert peer reviewers experienced in the topic of the article.  Every article is read first by the senior editors and a proprotion may be rejected if deficient in the journal's requirements or instructions.  If it passes this phase it will be sent for external expert peer-review, usually by three or more experts.  Peer-reviewers must declare any potential conflicts which are reviewed by the editors before the reviewer is allowed to review the article.  We aim to have an initial decision within 4 weeks (or less on average). Approximately 25% of submissions will finally pass the peer-review process.

Reviewers are chosen for their expertise, a track record of publications and their expertness, fairness and timeliness of reviews, as well as their independence from the submitting authors. Reviewers are asked to assess a paper's originality, priority, ethics, quality and the validity of the data presented.


Publication Frequency

The Journal accepts papers as they are ready and publishes full issues when they are fully compiled.  Each issue is a new volume that may contain both printed and on-line-only material. A new volume is published three to four times per year.


Open Access Policy

This journal provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge.



This journal utilizes the LOCKSS system to create a distributed archiving system among participating libraries and permits those libraries to create permanent archives of the journal for purposes of preservation and restoration. More...



Authors who publish with this journal agree to the following terms:

a. The journal will retain copyright under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

b. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.

c. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).


Policies on Conflict of Interest, Human and Animal rights, and Informed Consent

Conflict of Interest statements:

J-ATAMIS requires authors to declare all (actual and potential) conflicts of interests either personal or related to a close family member. All submitted manuscripts must include a ‘conflicts of interests’ statement at the end of the manuscript reporting all potential financial or non-financial conflicts.

Authors must disclose any potential conflicts of interests be they financial or non-financial.  Financial conflicts include:

  • Receiving fees, salary, honoraria, funding or reimbursements from an organization that may benefit or lose financially from the publication of the manuscript, either now or in the future.
  • Stock or share ownership in an organization that may benefit or lose financially from the publication of the manuscript, either now or in the future.
  • Registration or application for patents relating to the content of the manuscript.
  • Receiving fees, salary, honoraria, funding or reimbursements from an organization with an interest in any patents relating to the content of the manuscript.

Non-financial conflicts of interest (or private interests) may be personal, professional, political, academic, intellectual, ideological, or religious. If you are unsure whether you have a competing interest, please contact the Editor.

Commercial authors:

Authors from pharmaceutical companies and any other commercial organizations with any involvement with clinical trials should declare their interests as potential conflicts. They should also adhere to the Good Publication Practice guidelines for pharmaceutical companies (e.g.: http://www.bmj.com/content/339/bmj.b4330). This applies to any organizations or individuals that work for commercial interests, including freelance writers, contract research groups and communications organizations. The use of such bodies in preparation of a manuscript must be declared at the time of submission. 

Editors and Reviewers:

Editors and reviewers are required to declare any potential financial or non-financial conflicts of interests and will be removed from the peer review process should any such conflicts be identified.

Informed consent statements:

For all research involving human patients and volunteers, informed consent to participate in the study must be obtained from the participants (or legal guardian where the ethical committee requires this) and this statement must be made in the manuscript. Where images, material or specimens can be traced to individuals, written informed consent for the publication of these must be obtained from the participants (or appropriate legal guardian or next of kin if deceased) prior to submission.

Experimental research on animals must comply with institutional, national, or international guidelines, and have been approved by the appropriate ethics committee. The approving body and the legislated licence under which the work has taken place must be cited in the manuscript.

Human and animal rights statement:

All research reported in any submission must have adhered to all local, regional, institutional and national ethical guidelines for research on animals or on human subjects and had all necessary approvals and licences in place prior to the commencement of the research.  Approval from the relevant ethics committee must have been obtained for all reports that involve human patients or healthy volunteers, unless an adequate explanation is given.

Research involving human subjects, human material, or human data, must have been performed in accordance with the Declaration of Helsinki and must have been approved by an appropriate ethics committee or have been granted an exemption from requiring ethics approval -these must be verified upon request, so that the name of the appropriate committee and the registration number and title of the project must be provided on request.


Plagiarism Prevention

Barcaray Publishing encourages its editors to use iThenticate software (http://www.ithenticate.com) to detect instances of overlapping and duplicate text. The report from iThenticate will be made available to reviewers and editors and will be taken into account in the decisions regarding the manuscript.  No absolute number for decisions of an acceptable level of text similarity as each case is considered on its merits, for example a greater % similarity is allowed in Methods sections if standard methodologies are being described and a much lower tolerance exists for the Introduction or Discussion sections or in Editorials or Review articles.  In addition to overall text similarity the degree of similarity to text in any single article will be sought and a lower threshold for acceptable similarity will be applied.  Self-plagiarism will also be sought and excessive levels will be brought to the authors’ attention for correction.  All articles are reviewed for adequate citing of source material and any biases in favour or against original publication, either by individuals, research groups or nations will be investigated and may lead to the authors being warned or barred from future publication if repeated. 



Appeals and Complaints

Authors who wish to make a complaint should refer it to the Editor-in-Chief of the relevant journal. If a complaint has been made concerning the Editor-in-Chief the publisher will refer the matter to an experienced independent Editor-in-Chief of an unrelated journal for adjudication.